Retail investors are looking to adjust their portfolios on declining interest rates, with 76% planning to maintain or increase contributions, according to investment platform eToro's latest data. eToro US investment analyst Bret Kenwell joins Wealth to explain that retail investors are focusing more on risk assets like equities (^DJI, ^IXIC, ^GSPC) and crypto, while also moving to cash as an opportunistic strategy. "When we... dig through the data, we think it's more of an opportunistic move to cash, with investors looking to redeploy that later in the year on some sort of pullbacks in the market and in crypto," Kenwell tells Brad Smith. Watch the video above to hear more of Kenwell's analyst insights, including his thoughts on the cautious approach that Gen Z investors take on, as the demographic notably allocates more to cash and high-yield bonds (^TYX, ^TNX, ^FVX). To watch more expert insights and analysis on the latest market action, check out more Wealth here. This post was written by Josh Lynch
Banking giant JPMorgan (JPM) has forecastedthe next wave of cryptocurrency exchange-traded funds (ETFs)—focusing on Solana and XRP—could experience substantial growth if the U.S. Securities and Exchange Commission (SEC) gives the green light.
The Department of Health and Human Services, through the Centers for Medicare & Medicaid Services, announced the selection of 15 additional drugs covered under Medicare Part D for price negotiations. In accordance with the Inflation Reduction Act, the negotiations with participating drug companies for these 15 drugs will occur in 2025 and any negotiated prices will become effective in 2027, the agency said in a statement. The selected drug list for the second cycle of negotiations is: Novo Nordi
Morgan Stanley notes recent news reports suggest both President Biden and President-elect Trump are interested in extending the upcoming January 19 deadline to give TikTok more time to reach a suitable divestiture that would allow TikTok to keep operating in the U.S. Recent reports also suggest China may be contemplating allowing a divestiture, the analyst added. In this context of a divestiture looking “increasingly likely,” the firm outlines three reasons TikTok could potentially be a “strong
Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with Netflix (NFLX) to show Greta Gerwig’s “Narnia” movie on Imax’s screens. Based on the “well known Chronicles of Narnia book series, the movie will debut on Thanksgiving Day 2026 and will have a four-week window before launching on Netflix, the analyst tells investors in a research note. Roth views the announcement as a “significant deal” for Imax given its exclusivity. Net
The bull market has pushed the S&P 500 up 22% over the past year, but historically, the popular barometer has averaged about 10% returns annually. To help you in your search, three Motley Fool contributors believe Uber Technologies (NYSE: UBER), MercadoLibre (NASDAQ: MELI), and Cava Group (NYSE: CAVA) have the makings of long-term winners that can outperform the broader market over the next five years. John Ballard (Uber Technologies): Uber stock is up 162% since bottoming out in 2022, but the stock's flat performance over the past year sets up a great buying opportunity.
Oppenheimer lowered the firm’s price target on Coinbase (COIN) to $334 from $358 and keeps an Outperform rating on the shares. The firm believes the selloff in Coinbase shares since late December presents a buying opportunity. It predicts Q4 will be a “very good” quarter, sees upward earnings-estimate revisions for the out years, and potential for S&P 500 inclusion in 2025. In addition, the analyst expects regulatory clarity under a “pro-crypto” President Trump. As a leading, focused crypto play
Last year, five stocks supplied me with more than $500 of dividend income apiece. Here's a look at these leaders, which I expect will provide me with even more passive income in 2025. Last year, Energy Transfer (NYSE: ET) was my top income-producing stock.